Matthew W. Rosinack
SVP, Chief Accounting Officer, Bruker Cellular Analysis, Inc.
Companies
- Iovance BiotherapeuticsSVP, Finance (Int. PFO & PAO) Jul 10, 2025 to now1
- Bruker Cellular Analysis, Inc.SVP, Chief Accounting Officer Sep 22, 2020 to Jun 21, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Iovance Biotherapeutics IOVA89,129 shares3$1.2M at $13.92Jul 10, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3